Sequencing-based genetic tests to screen for mutations in BRCA1 and BRCA2 are recommended to individuals with a personal or family history of early onset and/or bilateral breast and/or ovarian cancer, or a history of male breast cancer. Here, BRCA2 is linked to ovarian cancer.